Serum prolactin level in multiple sclerosis patients

Journal of Research in Medical Sciences

Volumn 11, Issue 5, 2006, Pages 325-328

  Shafa, Mohammad Ali ^a   Vakilian, Alireza ^b   Poorebrahimi, Alireza ^c   Kahnali, Jafar Ahmady ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Emam Reza Hospital   (Iran)

Author keywords

Female; Male; Multiple sclerosis; Prolactin

Indexed keywords

PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE SYSTEM; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; SEX DIFFERENCE;

EID: 33846508478     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ropper AH, Brown RH. Adams and Victor principles of neurology. 8th ed. New York: McGraw-Hill Professional; 2005. p. 771-96.
2. Micheal J, Dawson O, Dawson D. Multiple sclerosis and other inflammatory demyelinating disease of the CNS. Neurology in clinical practice. Buther Worth Heinemann; 2000. p. 1431-1467.
3. Rowland LP, Miller JR. Multiple Sclerosis. Merritts Neurology. Lippincot Williams & Wilkins, 2005: 941-963.
4. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996; 17(1):64-102.
5. Grinsted L, Heltberg A, Hagen C, Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med 1989; 226(4):241-244.
6. Mellai M, Giordano M, D'Alfonso S, Marchini M, Scorza R, Giovanna DM et al. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum Immunol 2003; 64(2):274-284.
7. Reder AT, Lowy MT. Serum prolactin levels in active multiple sclerosis and during cyclosporin treatment. J Neurol Sci 1993; 117(1-2):192-196.
8. Harirchian MH, Sahraian MA, Shirani A. Serum prolactin level in patients with multiple sclerosis: a case control study. Med Sci Monit 2006; 12(4):CR177-CR180.
9. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13(3):227-231.
10. Draca S, Levic Z. The possible role of prolactin in the immunopathogenesis of multiple sclerosis. Med Hypotheses 1996; 47(2):89-92.
11. Heesen C, Gold SM, Bruhn M, Monch A, Schulz KH. Prolactin stimulation in multiple sclerosis - an indicator of disease subtypes and activity? Endocr Res 2002; 28(1-2):9-18.
12. Dogusan Z, Martens N, Stinissen P, Hellings N, Demotte N, Hooghe R et al. Effects of prolactin on cloned human T-lymphocytes. Endocrine 2003; 20(1-2):171-176.
13. Golovkin VI, Mikhailenko AA, Rakov AL. [Pathogenetic role of prolactinemia in multiple sclerosis]. Sov Med 1991; 10:15-17.
14. Azar ST, Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res 1999; 25(2):207-214.
15. Yamasaki K, Horiuchi I, Minohara M, Osoegawa M, Kawano Y, Ohyagi Y et al. Hyperprolactinemia in opticospinal multiple sclerosis. Intern Med 2000; 39(4):296-299.
16. Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand 1991; 84(5):403-406.